Related Experiment Video

Updated: Mar 29, 2026

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms
06:40

Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms

Published on: January 25, 2018

7.2K

MiR-16 regulates cell death in Alzheimer's disease by targeting amyloid precursor protein

B Zhang1, C-F Chen, A-H Wang

  • 1Department of Neurology, Shandong Provincial Hospital, Shandong University, Jinan, P.R. China. chencf301@163.com.

European Review for Medical and Pharmacological Sciences
|November 24, 2015
PubMed
Abstract

Insights

MicroRNA-16 (miR-16) is downregulated in Alzheimer's disease (AD) models. Restoring miR-16 levels reduces neuronal apoptosis and may offer a therapeutic strategy for AD.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • MicroRNAs (miRNAs) play crucial roles in regulating gene expression and cellular processes.
  • Dysregulation of miRNAs has been implicated in the pathogenesis of AD.

Purpose of the Study:

  • To investigate the role of microRNA-16 (miR-16) in Alzheimer's disease (AD).
  • To elucidate the mechanism of action of miR-16 in AD pathogenesis.
  • To identify potential therapeutic targets for AD.

Main Methods:

  • Establishment of cellular AD models using PC12 cells and primary hippocampal neurons.
  • Evaluation of miR-16 expression levels.
  • Manipulation of miR-16 levels using mimics and inhibitors to assess effects on cell apoptosis and viability.
  • Bioinformatics analysis, luciferase reporter assays, and gene expression analyses to identify and validate miR-16 targets.

Main Results:

  • miR-16 was significantly downregulated in cellular AD models.
  • Overexpression of miR-16 reduced apoptosis, while inhibition increased apoptosis in primary hippocampal neurons.
  • Amyloid precursor protein (APP) was identified as a direct target of miR-16.
  • Knockdown of APP decreased apoptosis and enhanced cell viability in the AD model.

Conclusions:

  • Downregulation of miR-16 contributes to neuronal apoptosis in AD.
  • miR-16 plays a significant role in the paracrine effects involved in AD development.
  • Targeting miR-16 or its downstream effectors like APP may represent a therapeutic avenue for AD.

More Related Videos

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

9.0K
Imaging the Intracellular Trafficking of APP with Photoactivatable GFP07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

12.4K

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K